Delivery Order SPE2DR25D6028-SPE2DR26FATPD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,414.38 to AmerisourceBergen Drug Corp for the supply of Levothyroxine Sodium, a synthetic thyroid hormone medication. The contract was competitively awarded on December 5, 2025, with an ultimate completion date of December 8, 2025, and is structured as a firm fixed price delivery order with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,887.81 to AmerisourceBergen Drug Corp for the supply of Levothyroxine Sodium, a thyroid hormone replacement medication. This firm fixed-price delivery order was issued on January 5, 2026, with an ultimate completion date of February 2, 2026, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, reflecting the contractor's capability...
- The Defense Logistics Agency awarded a delivery order for levothyroxine sodium to AmerisourceBergen Drug Corp on December 22, 2025, with a ceiling value of $2,962.37 and an ultimate completion date of January 21, 2026. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, which serves as the company's headquarters and...
- The Defense Logistics Agency awarded a delivery order valued at $1,626.99 to AmerisourceBergen Drug Corp for the supply of Levothyroxine 88 mcg tablets in quantities of 1,000 units. This contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, operates under a firm fixed-price structure with no set-aside designation. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on August 30, 2025, for the supply of Levothyroxine Sodium, a synthetic thyroid hormone medication commonly used in military and federal healthcare systems. This firm fixed-price delivery order, valued at $1,723.68 with an ultimate completion date of September 2, 2025, represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,008.90 to AmerSourceBergen Drug Corp on January 7, 2026, for the supply of Levothyroxine Sodium, a synthetic thyroid hormone medication commonly used to treat hypothyroidism. This firm fixed-price contract represents a child delivery order under AmerSourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Levothyroxine 150 MCG capsules (30-count units) with a ceiling value of $1,909.37. This firm fixed-price delivery order, with an ultimate completion date of December 11, 2025, is unclassified and carries no set-aside designation, indicating it was competitively awarded. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp...
- The Defense Logistics Agency awarded a $2,537.05 delivery order to AmerisourceBergen Drug Corp for levothyroxine sodium on December 29, 2025, with an ultimate completion date of January 27, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. Levothyroxine sodium is a synthetic thyroid hormone commonly used to treat hypothyroidism and is a critical pharmaceutical supply for...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Levothyroxine Sodium, a synthetic thyroid hormone used to treat hypothyroidism and other thyroid conditions. This firm fixed price delivery order has a ceiling value of $1,801.64 and is scheduled for completion by October 20, 2025. The contract was awarded without a set-aside designation through competitive procurement, with performance taking place at...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $92,170 to Amerisourcebergen Drug Corporation for 1000 tablets of 125 mcg levothyroxine. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The order is for delivery between July 12-13, 2023. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency manages the Department of Defense's global logistics network and supply...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FATPDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,413.13 to AmerisourceBergen Drug Corp for the supply of Levothyroxine 100 micrograms (30-count supply). The contract is a firm fixed-price delivery order with no set-aside designation, awarded on January 8, 2026, with an ultimate completion date of January 9, 2026. Performance will be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at up to $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and critical vendor for federal medical procurement needs, particularly serving military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply a comprehensive range of pharmaceutical products across multiple therapeutic domains through competitively awarded contracts with the Defense Logistics Agency. Levothyroxine is a thyroid hormone replacement medication commonly used in military and federal healthcare systems for managing thyroid disorders. This transaction exemplifies the routine, high-volume pharmaceutical supply chain that AmerisourceBergen maintains with the federal government through its prime vendor agreement with DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 1/7/26 |